Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 6/20 | 0.66 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.51 |
| ▸ | NAMPT | P43490 | 1/20 | 0.51 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CCR3 | P51677 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31372293 | 1.00 | EPHX1 (0.66) | EPHX1RAB9ARECQLSMN1; SMN2PRMT1 | |
| SCHEMBL31372373 | 1.00 | EPHX1 (0.66) | EPHX1RAB9ARECQLSMN1; SMN2PRMT1 | |
| SCHEMBL31372224 | 1.00 | EPHX1 (0.66) | EPHX1RAB9ARECQLSMN1; SMN2PRMT1 | |
| SCHEMBL23646267 | 1.00 | EPHX1 (0.66) | EPHX1RAB9ARECQLSMN1; SMN2PRMT1 | |
| SCHEMBL31372218 | 1.00 | EPHX1 (0.66) | EPHX1RAB9ARECQLSMN1; SMN2PRMT1 | |
| SCHEMBL23646221 | 1.00 | EPHX1 (0.66) | EPHX1RAB9ARECQLSMN1; SMN2PRMT1 | |
| SCHEMBL23646198 | 1.00 | EPHX1 (0.66) | EPHX1RAB9ARECQLSMN1; SMN2PRMT1 | |
| SCHEMBL23646188 | 0.86 | EPHX1 (0.59) | EPHX1RAB9APRMT1FOLH1EPHX2 | |
| SCHEMBL23646248 | 0.86 | EPHX1 (0.59) | EPHX1RAB9APRMT1FOLH1EPHX2 | |
| SCHEMBL23646259 | 0.86 | EPHX1 (0.59) | EPHX1RAB9APRMT1FOLH1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210221781-A1 | FATTY ACID ANALOGUES AND METHODS OF USE | LIN BIOSCIENCE INC. (TW) | 2021-07-22 | — | — | US | disclosed |
| US-20210221781-A1 | FATTY ACID ANALOGUES AND METHODS OF USE | LIN BIOSCIENCE INC. (TW) | 2021-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210221781-A1 | FATTY ACID ANALOGUES AND METHODS OF USE | ELOVL1, FADS1, ALOX5 | EPHX1 1873/4885RAB9A 1045/4885RECQL 1266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.